Alpha Family Trust’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-34,608
Closed -$5.04M 163
2024
Q3
$5.04M Hold
34,608
2.81% 9
2024
Q2
$4.75M Hold
34,608
2.78% 8
2024
Q1
$4.73M Hold
34,608
2.86% 9
2023
Q4
$4.7M Buy
34,608
+40
+0.1% +$4.88K 3.17% 8
2023
Q3
$4.23M Buy
34,568
+19
+0.1% +$2.42K 3.22% 8
2023
Q2
$4.39M Hold
34,549
3.06% 8
2023
Q1
$4.46M Hold
34,549
3.53% 7
2022
Q4
$4.54M Buy
+34,549
New +$4.46M 4.1% 6

Other funds holding IBB

Alpha Family Trust's IBB Position: Q4 2024 in Review

Alpha Family Trust sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 34,608 shares — an estimated $5.04M sold.

Alpha Family Trust first reported a position in IBB in Q4 2022 and held it in 8 quarters. The position peaked at $5.04M in Q3 2024. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

  • Alpha Family Trust reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
  • Alpha Family Trust sold 34,608 iShares Biotechnology ETF shares in Q4 2024, an estimated $5.04M.
  • Alpha Family Trust first reported a position in iShares Biotechnology ETF in Q4 2022 and held it in 8 quarters.
  • Alpha Family Trust's iShares Biotechnology ETF position peaked at $5.04M in Q3 2024.
  • 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Alpha Family Trust's 13F filing for Q4 2024, filed 14 Feb 2025.